- Trials with a EudraCT protocol (72)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
72 result(s) found for: Sugammadex.
Displaying page 1 of 4.
| EudraCT Number: 2007-006934-33 | Sponsor Protocol Number: 19.4.333 | Start Date*: 2008-04-02 |
| Sponsor Name:NV Organon | ||
| Full Title: A single center, open-label trial in subjects with severe renal impairment evaluating the dialysability of the sugammadex-rocuronium complex | ||
| Medical condition: Not applicable | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-006935-29 | Sponsor Protocol Number: 19.4.328 | Start Date*: 2008-06-12 |
| Sponsor Name:NV Organon | ||
| Full Title: A multi-center, parallel-group, comparative trial evaluating the efficacy, pharmacokinetics and safety of 4.0 mg.kg-1 sugammadex administered at 1-2 PTC in subjects with normal or severely impaired... | ||
| Medical condition: Not applicable | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FR (Completed) GB (Completed) NL (Completed) AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2019-000709-55 | Sponsor Protocol Number: SugaRoc | Start Date*: 2020-04-01 |
| Sponsor Name:Universitair Ziekenhuis Brussel | ||
| Full Title: Sugammadex dose-finding study for reversal of deep rocuronium-induced neuromuscular block | ||
| Medical condition: decurarisation | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2009-016857-16 | Sponsor Protocol Number: AGO/2009/010 | Start Date*: 2010-06-09 |
| Sponsor Name:University Hospital Ghent | ||
| Full Title: Dose finding study for effective reversal of a moderate rocuronium-induced neuromuscular block with sugammadex in morbidly obese patients | ||
| Medical condition: Morbidly obese patients | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-002911-18 | Sponsor Protocol Number: 19.4.313 | Start Date*: 2007-09-05 |
| Sponsor Name:NV Organon | ||
| Full Title: Comparison of the T4/T1 ratio measured by means of the TOF-Watch® SX with the reappearance of T4 measured by means of a peripheral nerve stimulator in adult subjects receiving 4.0 mg.kg-1 sugammade... | ||
| Medical condition: Not applicable | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Completed) AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2009-012763-34 | Sponsor Protocol Number: V.1 | Start Date*: 2009-12-28 |
| Sponsor Name:Medizinische Universität Wien, Univ. Klinik für Anästhesie, Allg. Intensivmedizin u Schmerztherapie | ||
| Full Title: Reversal of neuromuscular blockage in Patients with End Stage Hepatic Failure (listed for Liver Transplantation) | ||
| Medical condition: Patients with liver-failure undergoing surgery and receiving Rocuronium. Sugammadex is approved for recovery of Rocuronium. There are to date no clinical data to Sugammadex in patients with liver ... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2022-003325-22 | Sponsor Protocol Number: 2022-15944 | Start Date*: 2023-01-25 |
| Sponsor Name:RadboudUMC | ||
| Full Title: The immunomodulatory effect of sugammadex after total hip replacement surgery under neuraxial anaesthesia: a pilot study | ||
| Medical condition: Hip osteoarthritis | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-004666-34 | Sponsor Protocol Number: AITT2014/1 | Start Date*: 2014-03-17 |
| Sponsor Name:University of Debrecen, Medical and Health Science Center, Department of Anaesthesiology and Intensive Therapy | ||
| Full Title: Reversal of vecuronium induced residual neuromuscular block using sugammadex: a prospective, dobule-blind, randomized, controlled, dosefinding study | ||
| Medical condition: The effect of sugammadex dose on residual neuromuscular blockade will be investigated, therefore patients suffering from various conditions undergoing surgery in general anaesthesia with muscle rel... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: HU (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-002021-35 | Sponsor Protocol Number: ANR-1/14 | Start Date*: 2014-09-23 |
| Sponsor Name:Fondazione IRCCS Istituto Nazionale dei Tumori | ||
| Full Title: Decurarization After Thoracic Anesthesia - A prospective multicenter double-blind randomized trial comparing sugammadex vs neostigmine reversal after thoracic anesthesia | ||
| Medical condition: Neuromuscular block is commonly adopted during general anesthesia to facilitate tracheal intubation, mechanical ventilation and surgical manipulation. At the end of anesthesia it very important to ... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: IT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-002528-10 | Sponsor Protocol Number: SIVAA01 | Start Date*: 2017-07-06 |
| Sponsor Name:Vestfold Hospital Trust | ||
| Full Title: TOF trial: A randomized double blinded controlled Trial comparing low dose Of sugammadex and neostigmine aFter use of rocuronium during general anesthesia in patients undergoing non-cardiac surgery | ||
| Medical condition: The study population will include all patients >18 years scheduled for an elective surgical procedure undergoing general anesthesia with intravenous drugs and non-depolarizing NMBA (rocuronium), wi... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NO (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-000693-11 | Sponsor Protocol Number: MK-8616-169 | Start Date*: 2019-08-05 | |||||||||||
| Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
| Full Title: A Phase 4 Double-blinded, Randomized, Active Comparator-controlled Clinical Trial to Study the Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade ... | |||||||||||||
| Medical condition: Neuromuscular Blockade reversal | |||||||||||||
|
|||||||||||||
| Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) DK (Completed) FI (Completed) HU (Completed) NL (Completed) FR (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2008-008239-27 | Sponsor Protocol Number: SUNDRO | Start Date*: 2009-02-13 | ||||||||||||||||
| Sponsor Name:Technische Universität München | ||||||||||||||||||
| Full Title: Dosisfindungsstudie Sugammadex und Neostigmin bei geringer neuromuskulärer Restblockade (Sugammadex and Neostigmine dose finding study for reversal of residual neuromuscular blockade) | ||||||||||||||||||
| Medical condition: Dose finding study for sugammadex and/or neostigmine at residual neuromuscular blockade (whereas residual neuromuscular blockade is defined as a TOF of 0.5 in this study). | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: DE (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2009-013499-29 | Sponsor Protocol Number: SUNDRO20 | Start Date*: Information not available in EudraCT | ||||||||||||||||
| Sponsor Name:Technische Universität München | ||||||||||||||||||
| Full Title: Dosisfindungsstudie für Sugammadex und Neostigmin zur Reversierung einer geringen neuromuskulären Restblockade (train of four ratio 0,2) [Sugammadex and Neostigmine dose finding study for reversal ... | ||||||||||||||||||
| Medical condition: Dose finding study for sugammadex and/or neostigmine at residual neuromuscular blockade (whereas residual neuromuscular blockade is defined as a TOF of 0.2 in this study). | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: DE (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2007-007162-38 | Sponsor Protocol Number: 19.4.335 | Start Date*: 2008-03-17 |
| Sponsor Name:NV Organon | ||
| Full Title: A multi-center, open label trial, to show efficacy and safety of 4.0 mg.kg-1 sugammadex administered at a depth of neuromuscular blockade of 1-2 PTC induced by rocuronium in Chinese and European AS... | ||
| Medical condition: Not applicable | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DK (Completed) BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2013-002362-39 | Sponsor Protocol Number: TALVISUG01 | Start Date*: 2013-11-21 | ||||||||||||||||
| Sponsor Name:Consorci Mar Parc de Parc de Salut de Barcelona (Parc de Salut MAR) | ||||||||||||||||||
| Full Title: Reducing the dose of sugammadex 50% reverse the neuromuscular blockade of rocuronium effectively after general anesthesia. | ||||||||||||||||||
| Medical condition: Neuromuscular blockade is induced during general anesthesia, which often does not recover spontaneously, so it is necessary a pharmacological reversal. We believe that sugammadex at lower doses tha... | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: ES (Ongoing) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2008-002518-23 | Sponsor Protocol Number: 19.4.316 | Start Date*: 2008-10-16 |
| Sponsor Name:NV Organon, part of Schering-Plough Corporation | ||
| Full Title: A randomized, safety-assessor blinded trial comparing 4.0 mg.kg-1 sugammadex with placebo in adult subjects scheduled for surgery requiring profound neuromuscular blockade | ||
| Medical condition: Not applicable | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2014-005116-41 | Sponsor Protocol Number: AOP0071 | Start Date*: 2015-06-24 |
| Sponsor Name:University of Padova | ||
| Full Title: Postoperative pulmonary function in patients undergoing laparoscopic sleeve gastrectomy after administration of sugammadex and neostigmine. A double-blind, randomized controlled trial. | ||
| Medical condition: Reversal of rocuronium-induced neuromuscular blockade | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: IT (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-001683-22 | Sponsor Protocol Number: 1/2011AITT | Start Date*: 2011-06-10 |
| Sponsor Name:University of Debrecen, Medical and Health Science Center, Department of Anaesthesiology and Intensive Therapy | ||
| Full Title: Reversal of residual rocuronium neuromuscular block using sugammadex: a prospective, dobule-blind, randomized, controlled, dose-finding study | ||
| Medical condition: The effect of sugammadex dose on residual neuromuscular blockade will be investigated, therefore patients suffering from various conditions undergoing surgery in general anaesthesia with muscle rel... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: HU (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-002019-13 | Sponsor Protocol Number: 2015/3AITT | Start Date*: 2015-10-12 |
| Sponsor Name:University of Debrecen, Medical and Health Science Center, Department of Anaesthesiology and Intensive Therapy | ||
| Full Title: Reversal of deep pipecuronium neuromuscular block using sugammadex: a randomized, double-blind, dosefinding study | ||
| Medical condition: The effect of sugammadex dose on deep neuromuscular blockade will be investigated, therefore patients suffering from various conditions undergoing surgery in general anaesthesia with muscle relax... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: HU (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-002078-30 | Sponsor Protocol Number: REDNES06052013 | Start Date*: 2013-08-08 |
| Sponsor Name:Onze-Lieve-Vrouw Ziekenhuis | ||
| Full Title: Acceleromyography and diaphragm electromyographic activity during neostigmine or sugammadex enhanced recovery from moderate residual neuromuscular blockade after rocuronium 0.6 mg kg-1: a double bl... | ||
| Medical condition: We will compare usual care (neostigmine) with sugammadex for reversal of a moderate rocuronium-induced neuromuscular blockade and assess the effect on diaphragmatic EMG activity of sugammadex versu... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
